Biotechnology major Biocon today announced the setting up of a centre of excellence here for advanced learning in applied Bio-Sciences and said the bio-tech sector aims at a revenue of USD 100 billion by 2025.
The centre -- Biocon Academy -- would train and develop industry ready talent for India's Biopharma sector and enable global competitiveness, the company said.
"India has a potential of becoming a global innovation hub for Biotechnology. The Indian Biotech sector is estimated of the size of USD 11 billion today and it has grown at the CAGR of 20 per cent over last 10 years. The aim of the sector is to realise the revenue of USD 100 billion by 2025," Biocon Chairperson and MD Kiran Mazumdar-Shaw told reporters here.
"If this is the trajectory that we need to aim for, it may call for a very impotent talent pool, and a very large talent pool that enables us to achieve this goal," she added.
Stating that India has a very large opportunity to aim and achieve its goal of USD 100 billion by 2025, Mazumdar-Shaw said: "In order to do that we need appropriate talent to get us there."
She said: "Today as we all know there is a very large gap that exists between the quality of human capital available and the need of the industry. While we have the academic sector in our country graduating a large number of biotech professionals we do believe they are not industry ready."
"We have today over 725 biotech institutes in India, graduating 40,000 students per annum, but is it the appropriate relevant and rich talent pool we are getting? For which the answer is no, because barely 2,000 students get employed each year," she added.
Pointing out that the challenge is huge and immense, Mazumdar-Shaw said: "What BT Finishing Schools (Government of Karnataka initiative) and we at Biocon through the academy are planning to do each year, it is very very small scale; ....over the next few years if we were able to actually create or expand the talent pool by 10,000 each year - that will be quite a lot."